A groundbreaking drug has nearly doubled survival rates for pancreatic cancer patients, offering new hope in the fight ...

A growing number of people with stage 4 cancer are experiencing the power of this new medication. “It does provide options ...

We're on the cusp of a new era in cancer care – one that could dramatically improve survival and quality of life.

Learn more about Cancer Research UK's Unlock Cancer Breakthroughs campaign and help call on governments to remove the barriers holding back research.

Patients who have been treated for pancreatic cancer could benefit from a newly developed blood test that could identify tiny ...

Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Researchers have unveiled a breakthrough showing that a subset of ...

In the study, patients taking the drug lived longer compared to those undergoing chemotherapy. "This study showed that they doubled that. They went from 6.5 to like 13 months on average," Dr. Zev ...

New research offers fresh hope to patients with colorectal cancer, as advances in liquid biomarker technologies are ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

A novel immunotherapy could lead to a brain cancer breakthrough after showing promising results against glioblastoma, the ...

A new study on a groundbreaking pancreatic cancer drug finds that it has the potential to double survival rates for more than 90 percent of patients. Researchers are now exploring whether the drug, ...